- For specific information on sites and enrollment status on clinical trials with deforolimus and/or AP24534 in various solid tumor and blood cancers, respectively, please visit www.clinicaltrials.gov or please email us at TrialDesk@ariad.com.
- For more information on the open Phase 3 SUCCEED trial (Sarcoma Multi-Center Clinical Evaluation of the Efficacy of Deforolimus) for the treatment of patients with metastatic soft tissue or bone sarcomas, please visit www.succeedtrial.com or contact the U.S. toll-free number 1-877-621-2302 or the international number 1-617-621-2302.

